Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-993X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice ; volume:15 ; number:1 ; day:5 ; month:8 ; year:2014 ; pages:1-12 ; date:12.2014
Respiratory research ; 15, Heft 1 (5.8.2014), 1-12, 12.2014

Urheber
Noguchi, Shingo
Beteiligte Personen und Organisationen
Yatera, Kazuhiro
Wang, Ke-Yong
Oda, Keishi
Akata, Kentarou
Yamasaki, Kei
Kawanami, Toshinori
Ishimoto, Hiroshi
Toyohira, Yumiko
Shimokawa, Hiroaki
Yanagihara, Nobuyuki
Tsutsui, Masato
Mukae, Hiroshi
SpringerLink (Online service)

DOI
10.1186/s12931-014-0092-3
URN
urn:nbn:de:1111-2016052214394
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:44 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Noguchi, Shingo
  • Yatera, Kazuhiro
  • Wang, Ke-Yong
  • Oda, Keishi
  • Akata, Kentarou
  • Yamasaki, Kei
  • Kawanami, Toshinori
  • Ishimoto, Hiroshi
  • Toyohira, Yumiko
  • Shimokawa, Hiroaki
  • Yanagihara, Nobuyuki
  • Tsutsui, Masato
  • Mukae, Hiroshi
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Inhibition or knock out of Inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury

Inhibition or knock out of Inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

A critical role of AREG for bleomycin-induced skin fibrosis

A critical role of AREG for bleomycin-induced skin fibrosis

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Bleomycin-induced genome structural variations in normal, non-tumor cells

Bleomycin-induced genome structural variations in normal, non-tumor cells

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway

Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Verbundene Objekte